BioBridgeXAll companies

Kovina Therapeutics Inc.

Biotechnology company · Indianapolis, Indiana, United States

Kovina Therapeutics Inc. is a biotechnology company headquartered in Indianapolis, Indiana, United States. Its earliest recorded incorporation is in 2020. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Kovina Therapeutics at a glance

Typebiotechnology company
HeadquartersIndianapolis, Indiana, United States
Earliest incorporation on record2020
Employees (self-reported, 2023)3
SEC CIK1872402

What does Kovina Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $2.9 million in total (2022 to 2023). NIH funding came from the National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2 million sold (2021).

Frequently asked questions about Kovina Therapeutics

Where is Kovina Therapeutics headquartered?

Kovina Therapeutics Inc. is headquartered in Indianapolis, Indiana, United States.

What does Kovina Therapeutics do?

Kovina Therapeutics Inc. is a biotechnology company.

When was Kovina Therapeutics founded?

The earliest incorporation on record for Kovina Therapeutics Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences